PTN - Palatin rises as it completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171M
2023-12-20 08:29:09 ET
More on Palatin Tech
- Palatin Tech Q1 2024 Earnings Preview
- Palatin falls on common stock and warrants offering
- Seeking Alpha’s Quant Rating on Palatin Tech
For further details see:
Palatin rises as it completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171M